Abstract
Smad3 is a major transporter in the transforming growth factor β (TGF-β) signaling pathway. It is in charge of the transfer of TGF-β signal from the surface of the cell membrane into the nucleus. The TGF-β signal can be bound to the target gene in the nucleus and regulate its expression. Abnormalities in Smad3 expression level and functional status will lead to abnormal signal transduction, involving cell growth, proliferation, development, differentiation, migration, apoptosis and other basic life activities. This review focused on the differential expression of Smad3 in hepatocellular carcinoma (HCC) and the adjacent tissue. The character of Smad3 in HCC is outlined in three parts: Smad3 upstream signaling source, Smad3 self-assembly maturation and Smad3 downstream effects, which may provide a summary and reference for the follow-up study on Smad3. Key words: Transport protein, Smad3; Transforming growth factor β(TGF-β); Activin; Signal pathway; Hepatocellular carcinoma
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.